Kaoru Sugawara
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Kaoru Sugawara has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Ayuto Kodama
Advanced Research Center for Geriatric and Gerontology, Akita University, Akita 010-8543, Japan
3 shared publications - Hidetaka Ota
Advanced Research Center for Geriatric and Gerontology, Akita University, Akita 010-8543, Japan
3 shared publications - Takako Ohnuma
Advanced Research Center for Geriatric and Gerontology, Akita University, Akita 010-8543, Japan
3 shared publications - Tatsunori Shimizu
Advanced Research Center for Geriatric and Gerontology, Akita University, Akita 010-8543, Japan
2 shared publications - Fumio Yamamoto
Advanced Research Center for Geriatric and Gerontology, Akita University, Akita 010-8543, Japan
1 shared publication - Hiroyuki Kodama
Social Medical Corporation of Seiwakai, Akita 018-1401, Japan
1 shared publication
Latest Publications
- Open Access
- 1 October 2026
- Published by MDPI AG in Geriatrics
- Vol. 11 (5) , 138
Identifying Mild Cognitive Impairment from Routinely Collected Physical, Functional and Psychosocial Measures in Community-Dwelling Older Adults: A Comparative Machine-Learning and Regression Modelling Study in the Northern Japanese ORANGE Registry
Background: Community health check-ups routinely collect non-cognitive data. Whether these support mild cognitive impairment (MCI) triage, and whether machine learning outperforms regression, is unclear. Methods: Cross-sectional analysis of 2650 community-dwelling adults aged ≥ 65 in Akita, Japan (2018–2025). MCI was defined by the NCGG-FAT (1.5 SD, age/education-adjusted norms). Thirty-four pre-specified non-cognitive predictors were modelled using tree ensembles, penalised regression, other machine-learning families and simple reference scores, with stratified 70/30 splitting, DeLong tests, 100 repeated splits, training-derived thresholds, calibration metrics and decision-curve analysis. Results: MCI prevalence was 28.6%. Random forest discriminated best (ROC AUC 0.722, 95% CI 0.681–0.761; PR-AUC 0.542) and was well calibrated (slope 1.048; intercept −0.024), but its advantage over LASSO regression was marginal (ΔAUC +0.031, p = 0.044) and absent versus gradient boosting (p = 0.059). All multivariable models greatly outperformed the Kihon Checklist (AUC 0.550, p < 0.001). Neither operating point was deployable: at 0.5, sensitivity was 0.269 (166/227 cases missed); at the training-derived Youden threshold (0.321), sensitivity was 0.604, specificity 0.699, and PPV 0.445. Net benefit exceeded assess-all/assess-none between threshold probabilities 0.15–0.60. Conclusions: Routine non-cognitive data support moderate, well-calibrated MCI discrimination, but machine learning added little over regression. This is an exploratory triage aid requiring external validation.
- 1 October 2026
- Published by MDPI AG in Geriatrics
- Vol. 11 (5) , 138
Open AccessIdentifying Mild Cognitive Impairment from Routinely Collected Physical, Functional and Psychosocial Measures in Community-Dwelling Older Adults: A Comparative Machine-Learning and Regression Modelling Study in the Northern Japanese ORANGE Registry
Background: Community health check-ups routinely collect non-cognitive data. Whether these support mild cognitive impairment (MCI) triage, and whether machine learning outperforms regression, is unclear. Methods: Cross-sectional analysis of 2650 community-dwelling adults aged ≥ 65 in Akita, Japan (2018–2025). MCI was defined by the NCGG-FAT (1.5 SD, age/education-adjusted norms). Thirty-four pre-specified non-cognitive predictors were modelled using tree ensembles, penalised regression, other machine-learning families and simple reference scores, with stratified 70/30 splitting, DeLong tests, 100 repeated splits, training-derived thresholds, calibration metrics and decision-curve analysis. Results: MCI prevalence was 28.6%. Random forest discriminated best (ROC AUC 0.722, 95% CI 0.681–0.761; PR-AUC 0.542) and was well calibrated (slope 1.048; intercept −0.024), but its advantage over LASSO regression was marginal (ΔAUC +0.031, p = 0.044) and absent versus gradient boosting (p = 0.059). All multivariable models greatly outperformed the Kihon Checklist (AUC 0.550, p < 0.001). Neither operating point was deployable: at 0.5, sensitivity was 0.269 (166/227 cases missed); at the training-derived Youden threshold (0.321), sensitivity was 0.604, specificity 0.699, and PPV 0.445. Net benefit exceeded assess-all/assess-none between threshold probabilities 0.15–0.60. Conclusions: Routine non-cognitive data support moderate, well-calibrated MCI discrimination, but machine learning added little over regression. This is an exploratory triage aid requiring external validation.
- Open Access
The Cholinergic Receptor Nicotinic α3 Was Reduced in the Hippocampus of Early Cognitively Impaired Adult Male Mice and Upregulated by Nicotine and Cytisine in HT22 Cells
Ageing is a major risk factor for cognitive and physical decline, but its mechanisms remain poorly understood. This study aimed to detect early cognitive and physical changes, and to analyze the pathway involved by monitoring two groups of mice: a young and an adult group. The study has identified the types of molecules involved in the hippocampus. Adult mice (47 weeks) showed significantly reduced exploratory behavior compared to young mice (11 weeks), although spatial working memory showed no difference. In terms of physical function, grip strength was significantly reduced in adult mice. The Frailty Index (FI) further highlighted age-related changes in adult mice. To investigate the causes of cognitive decline, adult mice were categorized based on their declining cognitive function. Microarray analysis of their hippocampi revealed that the cholinergic receptor nicotinic α3 subunit (Chrna3) was significantly reduced in mice with cognitive decline compared to controls. Subsequent in vitro experiments showed that oxidative stress and cholinesterase inhibitors decreased Chrna3 expression, whereas nicotine and cytisine increased it. These results suggest that Chrna3 is a key factor in age-related cognitive decline. The development of therapeutic strategies targeting Chrna3 expression may offer promising avenues for preclinical and clinical research to mitigate cognitive ageing.
Open AccessThe Cholinergic Receptor Nicotinic α3 Was Reduced in the Hippocampus of Early Cognitively Impaired Adult Male Mice and Upregulated by Nicotine and Cytisine in HT22 Cells
Ageing is a major risk factor for cognitive and physical decline, but its mechanisms remain poorly understood. This study aimed to detect early cognitive and physical changes, and to analyze the pathway involved by monitoring two groups of mice: a young and an adult group. The study has identified the types of molecules involved in the hippocampus. Adult mice (47 weeks) showed significantly reduced exploratory behavior compared to young mice (11 weeks), although spatial working memory showed no difference. In terms of physical function, grip strength was significantly reduced in adult mice. The Frailty Index (FI) further highlighted age-related changes in adult mice. To investigate the causes of cognitive decline, adult mice were categorized based on their declining cognitive function. Microarray analysis of their hippocampi revealed that the cholinergic receptor nicotinic α3 subunit (Chrna3) was significantly reduced in mice with cognitive decline compared to controls. Subsequent in vitro experiments showed that oxidative stress and cholinesterase inhibitors decreased Chrna3 expression, whereas nicotine and cytisine increased it. These results suggest that Chrna3 is a key factor in age-related cognitive decline. The development of therapeutic strategies targeting Chrna3 expression may offer promising avenues for preclinical and clinical research to mitigate cognitive ageing.
- Open Access
- 28 August 2024
- Published by MDPI AG in Biomolecules
- Vol. 14 (9) , 1079
Unmodulated 40 Hz Stimulation as a Therapeutic Strategy for Aging: Improvements in Metabolism, Frailty, and Cognitive Function in Senescence-Accelerated Prone 10 Mice
With aging populations in many countries, including Japan, efforts to mitigate the aging-related decline in physical function have gained importance not only for improving individual quality of life but also for mitigating the effects of this loss of function on society. Impaired glucose tolerance, muscle weakness, and cognitive decline are well-known effects of aging. These interrelated factors can create a vicious cycle because impaired glucose tolerance can accelerate muscle weakness and cognitive decline. Unmodulated 40 Hz (u40Hz) stimulation is imperceptible to the human ear and has been reported to improve cognitive function in humans and mice. However, research on the effects of u40Hz stimulation is still limited. This study aimed to report the effects of u40Hz stimulation on glucose tolerance and muscle strength in senescence-accelerated prone (SAMP)-10 mice, a model of accelerated aging. SAMP-10 mice underwent five weeks of u40Hz stimulation followed by glucose-tolerance tests, cognitive and behavioral assessments, and frailty evaluations. In comparison with the control group, the u40Hz-stimulation group showed mitigation of age-related decline in glucose tolerance, a better frailty index (FI), and notably preserved muscle strength. Microarray analysis of stimulated muscle tissue revealed significant upregulation of β-oxidation genes and genes functioning downstream of peroxisome proliferator-activated receptor gamma, and significant downregulation of clock genes. These findings indicate the beneficial effects of u40Hz stimulation on glucose tolerance, muscle strength, and cognitive function, warranting further research in this area.
- 28 August 2024
- Published by MDPI AG in Biomolecules
- Vol. 14 (9) , 1079
Open AccessUnmodulated 40 Hz Stimulation as a Therapeutic Strategy for Aging: Improvements in Metabolism, Frailty, and Cognitive Function in Senescence-Accelerated Prone 10 Mice
With aging populations in many countries, including Japan, efforts to mitigate the aging-related decline in physical function have gained importance not only for improving individual quality of life but also for mitigating the effects of this loss of function on society. Impaired glucose tolerance, muscle weakness, and cognitive decline are well-known effects of aging. These interrelated factors can create a vicious cycle because impaired glucose tolerance can accelerate muscle weakness and cognitive decline. Unmodulated 40 Hz (u40Hz) stimulation is imperceptible to the human ear and has been reported to improve cognitive function in humans and mice. However, research on the effects of u40Hz stimulation is still limited. This study aimed to report the effects of u40Hz stimulation on glucose tolerance and muscle strength in senescence-accelerated prone (SAMP)-10 mice, a model of accelerated aging. SAMP-10 mice underwent five weeks of u40Hz stimulation followed by glucose-tolerance tests, cognitive and behavioral assessments, and frailty evaluations. In comparison with the control group, the u40Hz-stimulation group showed mitigation of age-related decline in glucose tolerance, a better frailty index (FI), and notably preserved muscle strength. Microarray analysis of stimulated muscle tissue revealed significant upregulation of β-oxidation genes and genes functioning downstream of peroxisome proliferator-activated receptor gamma, and significant downregulation of clock genes. These findings indicate the beneficial effects of u40Hz stimulation on glucose tolerance, muscle strength, and cognitive function, warranting further research in this area.